We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Exova Grp | LSE:EXO | London | Ordinary Share | GB00BKY7HG11 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 238.50 | 239.00 | 239.75 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMEXO
RNS Number : 9856P
Exova Group PLC
24 November 2016
EXOVA GROUP PLC
Notification of transactions of Directors and PDMRs
On 23 November 2016, Paul Barry, a person discharging managerial responsibilities ("PDMR"), exercised the vested portion of a bonus share award granted under the Exova Group plc Deferred Bonus Plan to acquire the number of ordinary shares of 1 pence each ("Shares") in Exova Group plc as set out below with an aggregate exercise price of GBP1.
1. Name 2. Status 3. Number of Shares under Option exercised ------------ ----------- -------------------------- Paul Barry PDMR 58,824 ------------ ----------- --------------------------
Following exercise, Paul Barry's total shareholding in the capital of Exova Group plc is 89,900 ordinary shares, representing 0.04 per cent. of the voting share capital of Exova Group plc.
1. Details of the person discharging managerial responsibilities/person closely associated ---- ----------------------------------------------------------- a) Name Paul Barry ---- ---------------------- ----------------------------------- 2. Reason for the notification ---- ----------------------------------------------------------- a) Position/status PDMR - Group Managing Director, Industries ---- ---------------------- ----------------------------------- b) Initial notification Initial notification / Amendment ---- ---------------------- ----------------------------------- 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ---- ----------------------------------------------------------- a) Name Exova Group plc ---- ---------------------- ----------------------------------- b) LEI ---- ---------------------- ----------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted ---- ----------------------------------------------------------- a) Description Ordinary shares of 1p each of the financial instrument, GB00BKY7HG11 type of instrument Identification code ---- ---------------------- ----------------------------------- b) Nature of Acquisition of shares following the transaction exercise of bonus share award granted under the Exova Group plc Deferred Bonus Plan ---- ---------------------- ----------------------------------- c) Price(s) and Price(s) Volume(s) volume(s) ---- ---------------------- ---------------------- ----------- Aggregate exercise price of GBP1 58,824 -------------------------------------------------- ----------- d) Aggregated information - Aggregated N/A volume - Price ---- ---------------------- ----------------------------------- e) Date of the 23 November 2016 transaction ---- ---------------------- ----------------------------------- f) Place of the London transaction ---- ---------------------- -----------------------------------
This notification is made in accordance with Article 19 of the Market Abuse Regulation and the Disclosure and Transparency Rules.
For and on behalf of Exova Group plc
Date: 24 November 2016
Neil MacLennan
General Counsel & Company Secretary
Telephone: 0131 333 8053
About Exova
Exova is one of the world's leading laboratory-based testing groups, trusted by organisations to test and advise on the safety, quality and performance of their products and operations. Headquartered in Edinburgh, UK, Exova operates 138 laboratories and offices in 33 countries and employs more than 4,300 people throughout Europe, the Americas, the Middle East, Asia/Asia Pacific and Africa.
Exova's capabilities help to extend asset life, bring predictability to applications, and shorten the time to market for customers' products, processes and materials. With over 90 years' experience, Exova specialises in testing across a number of key sectors ranging from Aerospace to Fire & Building Products; Oil & Gas and Industrials; Infrastructure & Environment; Automotive; and Health Sciences.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHUOONRNSAAUAA
(END) Dow Jones Newswires
November 24, 2016 04:00 ET (09:00 GMT)
1 Year Exova Chart |
1 Month Exova Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions